General MedicationsTOPICALGeneric

NEO-MEDROL ACETATE

METHYLPREDNISOLONE ACETATE; NEOMYCIN SULFATE

Standard Dose

0.25%;EQ 3.5MG BASE/GM

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview NEO-MEDROL ACETATE is listed in Drugs@FDA under application 060611 (ANDA).

Marketing status: Discontinued Active ingredient METHYLPREDNISOLONE ACETATE; NEOMYCIN SULFATE Form and strength CREAM;TOPICAL - 0.25%;EQ 3.5MG BASE/GM Sponsor PHARMACIA AND UPJOHN Submission history Latest submission status date: 1993-01-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview NEO-MEDROL ACETATE is listed in Drugs@FDA under application 060611 (ANDA). Marketing status: Discontinued Active ingredient METHYLPREDNISOLONE ACETATE; NEOMYCIN SULFATE Form and strength CREAM;TOPICAL - 0.25%;EQ 3.5MG BASE/GM Sponsor PHARMACIA AND UPJOHN Submission history Latest submission status date: 1993-01-22 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.